Amalgamated Bank’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-339
| Closed | -$4K | – | 2329 |
|
|
2025
Q4 | $4K | Sell |
339
-33
| -9% | -$395 | ﹤0.01% | 2797 |
|
|
2025
Q3 | $5K | Hold |
372
| – | – | ﹤0.01% | 2777 |
|
|
2025
Q2 | $5K | Hold |
372
| – | – | ﹤0.01% | 2761 |
|
|
2025
Q1 | $5K | Hold |
372
| – | – | ﹤0.01% | 2671 |
|
|
2024
Q4 | $7K | Hold |
372
| – | – | ﹤0.01% | 2603 |
|
|
2024
Q3 | $7K | Hold |
372
| – | – | ﹤0.01% | 2625 |
|
|
2024
Q2 | $8K | Sell |
372
-3,161
| -89% | -$84.3K | ﹤0.01% | 2562 |
|
|
2024
Q1 | $135K | Sell |
3,533
-1,164
| -25% | -$56.4K | ﹤0.01% | 1677 |
|
|
2023
Q4 | $316K | Sell |
4,697
-111
| -2% | -$7.73K | ﹤0.01% | 1627 |
|
|
2023
Q3 | $360K | Sell |
4,808
-140
| -3% | -$12.4K | ﹤0.01% | 1563 |
|
|
2023
Q2 | $456K | Sell |
4,948
-34
| -0.7% | -$3.03K | ﹤0.01% | 1479 |
|
|
2023
Q1 | $516K | Sell |
4,982
-340
| -6% | -$37.7K | ﹤0.01% | 1415 |
|
|
2022
Q4 | $614K | Sell |
5,322
-28
| -0.5% | -$3.26K | 0.01% | 1368 |
|
|
2022
Q3 | $580K | Sell |
5,350
-169
| -3% | -$24.2K | 0.01% | 1365 |
|
|
2022
Q2 | $996K | Sell |
5,519
-169
| -3% | -$30.2K | 0.01% | 1159 |
|
|
2022
Q1 | $971K | Sell |
5,688
-326
| -5% | -$61.5K | 0.01% | 1213 |
|
|
2021
Q4 | $1.26M | Sell |
6,014
-196
| -3% | -$40.5K | 0.01% | 1137 |
|
|
2021
Q3 | $1.2M | Sell |
6,210
-119
| -2% | -$29.3K | 0.01% | 1156 |
|
|
2021
Q2 | $1.79M | Buy |
6,329
+4,618
| +270% | +$1.25M | 0.01% | 1012 |
|
|
2021
Q1 | $362K | Sell |
1,711
-158
| -8% | -$37.8K | 0.01% | 1164 |
|
|
2020
Q4 | $367K | Buy |
1,869
+17
| +0.9% | +$3K | 0.01% | 1130 |
|
|
2020
Q3 | $305K | Sell |
1,852
-52
| -3% | -$8.56K | 0.01% | 1103 |
|
|
2020
Q2 | $264K | Buy |
+1,904
| New | +$175K | 0.01% | 1181 |
|
|
2020
Q1 | – | Sell |
-2,009
| Closed | -$220K | – | 1738 |
|
|
2019
Q4 | $220K | Sell |
2,009
-122
| -6% | -$11.8K | ﹤0.01% | 1594 |
|
|
2019
Q3 | $221K | Sell |
2,131
-23
| -1% | -$2.47K | ﹤0.01% | 1496 |
|
|
2019
Q2 | $276K | Buy |
2,154
+223
| +12% | +$31K | 0.01% | 1404 |
|
|
2019
Q1 | $246K | Buy |
1,931
+58
| +3% | +$7.36K | 0.01% | 1385 |
|
|
2018
Q4 | $234K | Buy |
+1,873
| New | +$320K | 0.01% | 1321 |
|
|
2018
Q3 | – | Sell |
-1,895
| Closed | -$304K | – | 1552 |
|
|
2018
Q2 | $304K | Buy |
+1,895
| New | +$242K | 0.01% | 1311 |
|
Other funds holding MED
SCP
VCM
Amalgamated Bank's MED Position: Q1 2026 in Review
Amalgamated Bank sold out of Medifast (MED) in Q1 2026, closing a stake of 339 shares — an estimated $4K sold.
Amalgamated Bank first reported a position in MED in Q2 2018 and held it in 29 quarters. The position peaked at $1.79M in Q2 2021. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.
- Amalgamated Bank reported no remaining Medifast position as of Q1 2026 after selling out during the quarter.
- Amalgamated Bank sold 339 Medifast shares in Q1 2026, an estimated $4K.
- Amalgamated Bank first reported a position in Medifast in Q2 2018 and held it in 29 quarters.
- Amalgamated Bank's Medifast position peaked at $1.79M in Q2 2021.
- 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.
Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.